Malignant neoplasm of left acoustic nerve
ICD-10 C72.42 is a billable code used to indicate a diagnosis of malignant neoplasm of left acoustic nerve.
C72.42 refers to a malignant neoplasm located on the left acoustic nerve, which is responsible for transmitting sound and balance information from the inner ear to the brain. This type of tumor can arise from Schwann cells, leading to a condition known as vestibular schwannoma or acoustic neuroma. Symptoms may include hearing loss, tinnitus, and balance disturbances. Imaging studies, particularly MRI, are crucial for diagnosis, as they provide detailed views of the tumor's size, location, and effect on surrounding structures. Molecular markers, such as mutations in the NF2 gene, may also be evaluated to understand the tumor's biology and potential treatment responses. Neurological function can be significantly impacted, necessitating a multidisciplinary approach for management, including surgical intervention, radiation therapy, and rehabilitation services. Accurate coding is essential for appropriate treatment planning and reimbursement.
Detailed audiological assessments and imaging reports.
Patients presenting with unilateral hearing loss and tinnitus.
Ensure clear documentation of symptoms and imaging findings to support the diagnosis.
Surgical reports detailing tumor resection and neurological assessments.
Patients undergoing surgical intervention for acoustic neuromas.
Documenting the extent of resection and any complications is crucial for accurate coding.
Used when surgical intervention is performed for a malignant neoplasm of the acoustic nerve.
Surgical reports must detail the procedure and any complications.
Neurosurgeons should document the extent of tumor resection and neurological assessments.
MRI is the preferred imaging modality for diagnosing malignant neoplasms of the acoustic nerve, providing detailed information about the tumor's size and location.